Pricing Log in Create free account

ImmunityBio, Inc. (IBRX) vs Bio-Techne Corp (TECH)

ImmunityBio, Inc. and Bio-Techne Corp are both Biotechnology companies. ImmunityBio, Inc. and Bio-Techne Corp are of similar size ($11.4B and $10.6B). ImmunityBio, Inc. has negative trailing earnings, so its P/E is not meaningful; Bio-Techne Corp trades at 62.0×. ImmunityBio, Inc. grew revenue faster over the last twelve months: 192.9% against −0.38%. Bio-Techne Corp has the higher net margin (15.0% vs −598.6%) and the higher return on invested capital (7.70% vs 0.00%). Across the 18 metrics below, Bio-Techne Corp leads on 11 and ImmunityBio, Inc. on 7.

Valuation

Metric IBRX TECH Biotechnology median
P/E n/m 62.00 8.50
P/S 58.14 9.31 9.71
P/B n/m 5.37 2.13
Price to free cash flow n/m 42.98 20.82
EV/EBITDA n/m 32.24 0.64
EV/Sales 63.56 9.27 9.21
Earnings yield (10.57%) 1.61% (33.15%)
Free cash flow yield (2.99%) 2.33% (25.50%)

Profitability

Metric IBRX TECH Biotechnology median
Gross margin 99.34% 65.77% 65.16%
Operating margin (151.88%) 20.73% 0.00%
Net margin (598.56%) 14.97% 0.00%
Free cash flow margin (173.76%) 21.66% 0.00%
Return on equity 122.85% 9.03% (56.36%)
Return on assets (192.58%) 7.07% (48.04%)
Return on invested capital 0.00% 7.70% 0.00%

Growth

Metric IBRX TECH Biotechnology median
Revenue growth (TTM) 192.92% (0.38%) 6.02%
EPS growth (last fiscal year) 38.71% 152.17% 30.26%
Revenue growth, 5-year CAGR 184.76% 5.47% 9.41%
Net income growth, 5-year CAGR 0.00% 5.31% 0.00%

Health

Metric IBRX TECH Biotechnology median
Debt to equity (0.74) 0.09 0.00
Current ratio 5.72 4.55 4.72
Net debt to EBITDA (0.97) (0.19) 0.96

Dividend

Metric IBRX TECH Biotechnology median
Dividend yield — 0.44% 0.09%
Payout ratio — 0.28 —

Size

Metric IBRX TECH Biotechnology median
Market cap 10.60b 11.37b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack